volume 7 issue 6 pages 813-820

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.

Mariapia A Degli-Esposti
William C Dougall
Pamela J Smolak
Jennifer Y. Waugh
Craig A. Smith
Raymond G. Goodwin
Publication typeJournal Article
Publication date1997-12-01
scimago Q1
wos Q1
SJR12.163
CiteScore40.8
Impact factor26.3
ISSN10747613, 10974180
Infectious Diseases
Immunology
Immunology and Allergy
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
Journal of Biological Chemistry
29 publications, 4.36%
Journal of Immunology
29 publications, 4.36%
Oncogene
21 publications, 3.16%
Cancer Research
15 publications, 2.26%
Vitamins and Hormones
15 publications, 2.26%
Cell Death and Differentiation
14 publications, 2.11%
Blood
14 publications, 2.11%
Biochemical and Biophysical Research Communications
10 publications, 1.5%
Cancers
10 publications, 1.5%
International Journal of Cancer
10 publications, 1.5%
British Journal of Cancer
9 publications, 1.35%
Cancer Letters
8 publications, 1.2%
Molecular Cancer Therapeutics
8 publications, 1.2%
BMC Cancer
7 publications, 1.05%
British Journal of Haematology
7 publications, 1.05%
Journal of Cellular Biochemistry
7 publications, 1.05%
Oncotarget
6 publications, 0.9%
International Journal of Molecular Sciences
6 publications, 0.9%
Apoptosis : an international journal on programmed cell death
6 publications, 0.9%
Cancer Gene Therapy
6 publications, 0.9%
FEBS Letters
6 publications, 0.9%
Journal of Experimental Medicine
6 publications, 0.9%
Laboratory Investigation
5 publications, 0.75%
Hepatology
5 publications, 0.75%
Leukemia
5 publications, 0.75%
Journal of Cellular Physiology
5 publications, 0.75%
Clinical Cancer Research
5 publications, 0.75%
Journal of Neuroimmunology
4 publications, 0.6%
Human Gene Therapy
4 publications, 0.6%
5
10
15
20
25
30

Publishers

20
40
60
80
100
120
140
160
Springer Nature
152 publications, 22.86%
Elsevier
139 publications, 20.9%
Wiley
91 publications, 13.68%
American Association for Cancer Research (AACR)
30 publications, 4.51%
American Society for Biochemistry and Molecular Biology
29 publications, 4.36%
The American Association of Immunologists
29 publications, 4.36%
MDPI
27 publications, 4.06%
Taylor & Francis
15 publications, 2.26%
American Society of Hematology
14 publications, 2.11%
Ovid Technologies (Wolters Kluwer Health)
10 publications, 1.5%
Frontiers Media S.A.
8 publications, 1.2%
American Society for Microbiology
8 publications, 1.2%
Oxford University Press
8 publications, 1.2%
Mary Ann Liebert
7 publications, 1.05%
Impact Journals
6 publications, 0.9%
Hindawi Limited
6 publications, 0.9%
Rockefeller University Press
6 publications, 0.9%
Baishideng Publishing Group
4 publications, 0.6%
Public Library of Science (PLoS)
4 publications, 0.6%
Cold Spring Harbor Laboratory
4 publications, 0.6%
Portland Press
3 publications, 0.45%
American Society for Clinical Investigation
2 publications, 0.3%
Spandidos Publications
2 publications, 0.3%
SAGE
2 publications, 0.3%
Federation of American Societies for Experimental Biology (FASEB)
2 publications, 0.3%
American Chemical Society (ACS)
2 publications, 0.3%
Royal Society of Chemistry (RSC)
2 publications, 0.3%
Pleiades Publishing
2 publications, 0.3%
Japanese Society of Animal Reproduction
2 publications, 0.3%
20
40
60
80
100
120
140
160
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
665
Share
Cite this
GOST |
Cite this
GOST Copy
Degli-Esposti M. A. et al. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. // Immunity. 1997. Vol. 7. No. 6. pp. 813-820.
GOST all authors (up to 50) Copy
Degli-Esposti M. A., Dougall W. C., Smolak P. J., Waugh J. Y., Smith C. A., Goodwin R. G. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. // Immunity. 1997. Vol. 7. No. 6. pp. 813-820.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S1074-7613(00)80399-4
UR - https://doi.org/10.1016/S1074-7613(00)80399-4
TI - The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.
T2 - Immunity
AU - Degli-Esposti, Mariapia A
AU - Dougall, William C
AU - Smolak, Pamela J
AU - Waugh, Jennifer Y.
AU - Smith, Craig A.
AU - Goodwin, Raymond G.
PY - 1997
DA - 1997/12/01
PB - Elsevier
SP - 813-820
IS - 6
VL - 7
PMID - 9430226
SN - 1074-7613
SN - 1097-4180
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{1997_Degli-Esposti,
author = {Mariapia A Degli-Esposti and William C Dougall and Pamela J Smolak and Jennifer Y. Waugh and Craig A. Smith and Raymond G. Goodwin},
title = {The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.},
journal = {Immunity},
year = {1997},
volume = {7},
publisher = {Elsevier},
month = {dec},
url = {https://doi.org/10.1016/S1074-7613(00)80399-4},
number = {6},
pages = {813--820},
doi = {10.1016/S1074-7613(00)80399-4}
}
MLA
Cite this
MLA Copy
Degli-Esposti, Mariapia A., et al. “The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain..” Immunity, vol. 7, no. 6, Dec. 1997, pp. 813-820. https://doi.org/10.1016/S1074-7613(00)80399-4.